The recent study on the lipid disorder treatment market covers an in-depth analysis of the market on the basis of drug type, distribution channel, and geography. The report also covers the country level analysis within the regions as well. Additionally, the report covers the key trends in the market along with drivers and restraint during the forecast period 2018-2023. According to the report titled “Lipid Disorder Treatment Market – Forecast from 2018 to 2023”, the market is estimated to grow at a moderate pace during the forecast period.

The report has segmented the lipid disorder treatment market by drug type (lovastatin, atorvastatin, rosuvastatin, others), by distribution channel (offline, online) and by geography such as North America (United States, Canada, Mexico, others), South America (Brazil, Argentina, others), Europe (Germany, France, United Kingdom, Spain, others), Middle East and Africa, and Asia Pacific (China, Japan, Korea, India, others). The growing prevalence of cardiovascular disease is increasing the probability of an individual suffering from lipid disorders. In fact, in the United States, more than 12% of adults aged 20 and older had total cholesterol higher than 240 mg/dL, and more than 18% had high-density lipoprotein (HDL, or “good”) cholesterol levels less than 40 mg/dL (source: Centre for Disease Control and Prevention).

Asia Pacific is estimated to grow rapidly during the forecast period.

The growing focus by the government of emerging economies like India, China, and Philippines among others to increase the access to healthcare services to the individuals is expected to drive the Asia Pacific lipid disorder treatment market. Simultaneously, the steady improvement in the health insurance coverage in the region is further anticipated to augment the growth of the market.

Some of the major players discussed in the reports are Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd., Merck & Co., and Pfizer Inc. among others.

About Us:

Knowledge Sourcing Intelligence (KSI) is a market research and consulting organization based out of India. KSI publishes research studies spanning across ten industry verticals. KSI has a team of experienced and young professionals with a singular focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports per year centring on niche and latest technologies. We engage with key decision makers and stakeholders across the value chain to provide clients with a detailed analysis and bird’s-eye view of the market with whole market dynamics, statistical forecasts, competitive analysis, key trends, market drivers and challenges and strategic recommendations for making informed decisions. Our success lies in the effort of our analysts who strive to meet client expectations by delivering quality work within the stipulated deadlines.

The recent study on the global human drugs for veterinary use market covers an in-depth analysis of the market on the basis of medication type, drug type, and geography. The report also covers the country level analysis within the regions as well. Additionally, the report covers the key trends in the market along with drivers and restraints during the forecast period 2018-2023. According to the report titled “Global Human Drugs for Veterinary Use Market – Forecasts from 2018 to 2023”, the market is expected to surge at a good CAGR by 2023.

The report is segmented by medication type as Antibiotics, Non-steroidal anti-inflammatories, Opioid pain relievers, Chemotherapeutics, and Others; by drug type as Penicillin, Prednisone and Prednisolone, Diazepam, and Others and by geography as North America (USA, Canada, Mexico, and Others), South America (Brazil, Argentina, and Others), Europe (Germany, France, United Kingdom, Spain, and Others), Middle East and Africa (Saudi Arabia, Israel, and Others), and Asia Pacific (China, Japan, South Korea, India, and Others). Some drugs for use as veterinary medicines are taken by humans as well. These are also known as human drugs for veterinary use which include antibiotics, non-steroidal anti-inflammatories, and opioid pain relievers among others. The growing number of veterinary practitioners, and growing pet healthcare services are driving the growth of the global human drugs for veterinary use market during the forecast period. In addition, rising funding research programmes will further provide an opportunity to emanating market growth during the forecast period and beyond.

Growing number of veterinary practitioners is boosting the growth of the global human drugs for veterinary use market during the forecast period.

The modern veterinary profession is changing continuously which include the greater use of technology where more and more veterinary professionals are opting to specialize. This is due to the fact that the current pet owners’ expectations are rising where they are interested in receiving personalized attention with a high quality of services at competitive prices. Also, veterinary practices owned by corporates is poised to increase leading to certain benefits including economies of scale, efficient protocols, and standardization of care. Human drugs for veterinary use hold importance in treating pets or companion animals in addition to farm animals and may require a Veterinarian prescription as well owing to the risks of side-effects from medicines used for humans and may cause deleterious effects.

United States from the North American region holds a dominant share in the market

North America human drugs for veterinary use market is expected to hold the largest market share during the forecast period owing to the highest health spending of the United States among the developed nations. Also, there is a high number of pet population in the United States, in addition to the growing number of veterinarians which include around 65 percent of females, more in number than males. Furthermore, certain agencies in the United States like the American Veterinary Medical Association, AVMA, headquartered in Schaumburg, IL is working efficiently with its counterparts worldwide aiming towards advancements in veterinary sciences and practice in order to improve animal and human health.

Contact:

The recent study on the Programmable Logic Devices Market covers an in-depth analysis of the market on the basis of type, industry vertical, and geography. The report also covers the country level analysis within the regions as well. Additionally, the report covers the key trends in the market along with drivers and restraint during the forecast period 2019-2024. According to the report titled “Programmable Logic Devices Market– Forecast from 2019 to 2024”, the market is estimated to grow at a CAGR of 3.96% to reach a market size of US$6.195 billion by the end of the forecast period. The report has segmented the programmable logic market by type (programmable logic array, complex programmable logic device, field programmable gate array, others), by industry vertical (communication, consumer electronics, automotive, manufacturing) and by geography such as Americas (United States, Canada, Brazil, others), Europe Middle East and Africa (Germany, France, United Kingdom, Italy, others), and Asia Pacific (China, Japan, India, Taiwan, others).

The growing focus by the manufacturers to reduce the product development time is expected to boost the growth of the market. Furthermore, the ability of the PLD’s to reduce the risk associated with product development while simultaneously reducing the number of components, which tends to reduce the PCB assembly, test, and repair cost is further anticipated to supplement the growth of the market.

Asia Pacific is estimated to hold a significant share in the market

There is a growing trend of shifting manufacturing facilities from the developed region to Asia Pacific, more specifically, in countries like India, China, Vietnam, and Philippines among others on account of the ability to offer skilled and relatively inexpensive labor and cheap electricity, thus, attracting, significant foreign investment. Moreover, production of industrial, aerospace, and military equipment are witnessing a rapid upsurge in the region, which is further providing the revenue generation opportunity for the PLD’s manufacturers from the region.

Some of the major players discussed in the reports are Xilinx, Inc., Microchip Technology Inc., and Intel Corporation among others.

About Us:

Knowledge Sourcing Intelligence (KSI) is a market research and consulting firm based out of India. KSI publishes research studies spanning across ten industry verticals. KSI has a team of experienced and young professionals with a singular focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports per year centring on niche and latest technologies. We engage with key decision makers and stakeholders across the value chain to provide clients with a detailed analysis and bird’s-eye view of the market with whole market dynamics, statistical forecasts, competitive analysis, key trends, market drivers and challenges and strategic recommendations for making informed decisions. Our success lies in the effort of our analysts who strive to meet client expectations by delivering quality work within the stipulated deadlines.

Contact: